`
Wednesday, 28 June 2017

Japan News

  • Mednet, Biovisiq deal helps in zero-delay of trials

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2013

    Singapore: AG Mednet signed a master services agreement with Biovisiq, a Japanese imaging core laboratory (ICL), to reduce image-related query stoppages in clinical trials, which can delay ...Read more

  • Singulex's cardiovascular biomarker granted Japanese patent

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2015

    Singulex Inc., California-based developer and provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, announced that the Japanese Patent Office ha...Read more

  • Chugai Pharma to set up sales unit in China

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2013

    Singapore: With a capital of $30 million, Tokyo based Chugai Pharmaceutical has announced to establish a wholly owned drug import and sales unit in China in March. The company said that Ch...Read more

  • Astellas, FibroGen start CKD anemia trial in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013

    Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-4592 for the treatment of anemia associated with chronic kidney disea...Read more

  • Cancer-specific killer T cells created from iPS cells

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2013

    Singapore: Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan have succeeded, for the first time, in creating cancer-specific immune system cells, called killer ...Read more

  • Will Japan be able to reduce its generic drug prices?

    Japan |  Analysis | By Saptarshi Chaudhuri | 0 Comment | 21 May, 2013

    The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it records annual sales of approximately $64.5 billion (...Read more

  • Life Tech signs agreement with iPS Academia Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012

    Singapore: Life Technologies has signed a non-exclusive agreement with iPS Academia Japan for its induced pluripotent stem (iPS) cell patent portfolio. The worldwide license will enable Lif...Read more

  • Nagoya scientists discover new molecules that change circadian rhythm

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2015

    A team of chemists and biologists at the Institute of Transformative Bio-Molecules (ITbM), Nagoya University, Japan, have succeeded in finding new molecules that change the circadian rhythm...Read more

  • BioDiem protozoan drug to get Japanese patent

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013

    Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Japanese patent for its novel antimicrobial compound, BDM-I. The patent...Read more

  • Eisai, Nihon Medi-Physics to work on dementia intervention

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015

    Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement to contribute to the diagnosis and treatment of Dementia with Lewy b...Read more

  • R-Tech Ueno acquires right to develop Santen Pharma's ophthalmic solution

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015

    R-Tech Ueno Ltd, headquartered in Tokyo, has acquired the right to develop and commercialize DE-105 from Santen Pharmaceutical Co. Ltd. DE-105 is a treatment targeting at persistent corne...Read more

  • French firm successfully completes Ph I trial of diabetes drug in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 May, 2015

    Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully conculded phase 1 clinical trial of its lead candidate, Imeglimin, in J...Read more

  • Tarceva tablets with Nexavar show no improvement

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012

    Singapore: A phase III trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexavar (sorafenib) tablets did not show improvement in overall survival of...Read more

  • Mylan signs a settlement agreement with OSI Pharma

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013

    Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Japan's Astellas, Pfizer and Roche subsidiary Genentech that will resolv...Read more

  • Sale of wound care devices spurs in Asia-Pacific: Frost & Sullivan analysis report

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013

    Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in Asia Pacific as lower bed capacity in hospitals and the trend toward...Read more

  • Biogen inks autoimmune deal with Mitsubhishi Tanabe pharma

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2015

    Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan's Mitsubishi Tanabe pharma. The deal, worth more than $500 millin, gi...Read more

  • Japan approves Daiichi Sankyo's Cravit Injections

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2015

    Tokyo: Daiichi Sankyo Company, Limited has obtained approval for partial changes concerning a supplementary indication of their new quinolone antibacterial injections, Cravit Intravenous D...Read more

  • Synageva BioPharma seeks approval for Kanuma in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2015

    NASDAQ-listed Synageva BioPharma Corp. has submitted the New Drug Application (NDA) for Kanuma (sebelipase alfa) to the Ministry of Health, Labour and Welfare in Japan for the treatment of ...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls